Martin D. Phillips

1.3k total citations
16 papers, 978 citations indexed

About

Martin D. Phillips is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Martin D. Phillips has authored 16 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Surgery and 4 papers in Genetics. Recurrent topics in Martin D. Phillips's work include Platelet Disorders and Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Hemophilia Treatment and Research (3 papers). Martin D. Phillips is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Hemophilia Treatment and Research (3 papers). Martin D. Phillips collaborates with scholars based in United States, United Kingdom and Japan. Martin D. Phillips's co-authors include Susan C. Weil, Charles Schweizer, Raffit Hassan, Ira Pastan, Deborah K. Armstrong, Robert L. Coleman, Lloyd J. Old, Steven J. Cohen, Elad Sharon and Daniel A. Laheru and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Martin D. Phillips

15 papers receiving 936 citations

Peers

Martin D. Phillips

ONCOL

PRM

HEMAT

J. Casper Germany

J. L. Pico France

Steve Nicholson United Kingdom

Luis E. De Las Casas United States

Elżbieta Nowara Poland

I Tepler United States

A.B.W. Nethersell United Kingdom

P H de Mulder Netherlands

Michele De Nictolis Italy

Antonello D. Cabras Italy

J. Casper Germany

Martin D. Phillips

221 ×0.6

ONCOL

107 ×0.4

PRM

395 ×2.1

HEMAT

120 ×0.7

258 ×1.7

Citations per year, relative to Martin D. Phillips Martin D. Phillips (= 1×) peers J. Casper

Countries citing papers authored by Martin D. Phillips

Since Specialization

Citations

This map shows the geographic impact of Martin D. Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin D. Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin D. Phillips more than expected).

Fields of papers citing papers by Martin D. Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin D. Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin D. Phillips. The network helps show where Martin D. Phillips may publish in the future.

Co-authorship network of co-authors of Martin D. Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Martin D. Phillips. A scholar is included among the top collaborators of Martin D. Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin D. Phillips. Martin D. Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Phillips, Martin D.. (2022). The Life and Theology of Alexander Knox: Anglicanism in the Age of Enlightenment and Romanticism. 14(1). 105–106.

Armstrong, Deborah K., et al.. (2013). Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer. Gynecologic Oncology. 129(3). 452–458. 114 indexed citations

Farrell, Colm, Charles Schweizer, Susan C. Weil, et al.. (2012). Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer. Cancer Chemotherapy and Pharmacology. 70(5). 727–734. 15 indexed citations

Kim, Kenneth H., Danijela Jelovac, Deborah K. Armstrong, et al.. (2012). Phase I safety study of farletuzumab, carboplatin, and pegylated liposomal doxorubicin (PLD) in patients with platinum-sensitive epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 30(15_suppl). 5062–5062. 6 indexed citations

Konner, Jason, Katherine M. Bell‐McGuinn, Paul Sabbatini, et al.. (2010). Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study. Clinical Cancer Research. 16(21). 5288–5295. 133 indexed citations

Hassan, Raffit, Steven J. Cohen, Martin D. Phillips, et al.. (2010). Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers. Clinical Cancer Research. 16(24). 6132–6138. 160 indexed citations

Hassan, Raffit, Wolfgang Ebel, Eric Routhier, et al.. (2007). Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.. PubMed. 7. 20–20. 155 indexed citations

Ebel, Wolfgang, Eric Routhier, Brian Foley, et al.. (2007). Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.. PubMed. 7. 6–6. 113 indexed citations

Kuang, Shao-Qing, Sumera N. Hasham, Martin D. Phillips, et al.. (2001). Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas. Blood. 97(6). 1549–1554. 29 indexed citations

10.

Phillips, Martin D., et al.. (1998). von Willebrand Disease: Recent Advances in Pathophysiology and Treatment. The American Journal of the Medical Sciences. 316(2). 77–86. 10 indexed citations

11.

Phillips, Martin D., et al.. (1998). von Willebrand Disease: Recent Advances in Pathophysiology and Treatment. The American Journal of the Medical Sciences. 316(2). 77–86. 16 indexed citations

12.

Phillips, Martin D., et al.. (1997). Successful Treatment of Acquired Hemophilia with Oral Immunosuppressive Therapy. Annals of Internal Medicine. 127(3). 206–209. 79 indexed citations

13.

Kroll, Stephen S., Michael Miller, Gregory P. Reece, et al.. (1995). Anticoagulants and Hematomas in Free Flap Surgery. Plastic & Reconstructive Surgery. 96(3). 643–647. 93 indexed citations

14.

Cohen, Lewis, Nancy B. McWilliams, William H. Zinkham, et al.. (1995). Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports. American Journal of Hematology. 50(4). 269–276. 32 indexed citations

15.

Guo, Zhao-Zeng, Mark Weinstein, Martin D. Phillips, & Michael H. Kroll. (1993). Mr 6,400 aurin tricarboxylic acid directly activates platelets. Thrombosis Research. 71(1). 77–88. 16 indexed citations

16.

Phillips, Martin D., et al.. (1991). Granulocyte proteases do not process endothelial cell‐derived unusually large von willebrand factor multimers to plasma vWF in vivo. American Journal of Hematology. 37(2). 80–83. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact